Literature DB >> 8284092

Epidermal growth factor increases antioxidant enzyme and surfactant system development during hyperoxia and protects fetal rat lungs in vitro from hyperoxic toxicity.

L T Price1, Y Chen, L Frank.   

Abstract

Epidermal growth factor (EGF) has been shown to accelerate fetal lung maturation in rabbits, lambs, and rhesus monkeys in vivo and increase surfactant synthesis in vitro. Its effect on the maturation of the lung antioxidant enzyme system, however, is unknown. We studied the effect of EGF (10 nM) on 19-d fetal rat lung explant cultures in serum-free medium in air/5% CO2 or > 90% O2/5% CO2 compared with similarly grown control cultures in air or hyperoxia at 72 h. Fetal lung activities of superoxide dismutase and catalase were unchanged by EGF in air, whereas glutathione peroxidase activity was significantly decreased (p < 0.05 versus air control). However, in hyperoxia, EGF-treated fetal lung cultures had significantly elevated superoxide dismutase and catalase activities (p < 0.01) versus O2-exposed controls, and glutathione peroxidase activity similar to that of controls. The mRNA levels for all the antioxidant enzymes showed patterns similar to the enzyme activities except in the case of Cu,Zn-superoxide dismutase mRNA, which increased in EGF-air cultures. EGF decreased the rate of 3H-choline incorporation into disaturated phosphatidylcholine in air (p < 0.01 versus air control), but increased disaturated phosphatidylcholine synthesis in response to hyperoxia (p < 0.01 versus O2 control). The histologic appearance of EGF-treated cultures in O2 was superior to that of O2-exposed controls, which showed thickened septal walls, decreased surfactant in the air spaces, and epithelial cell mitochondrial swelling. EGF therefore accelerates antioxidant enzyme and disaturated phosphatidylcholine maturation under hyperoxic conditions and protects fetal rat lung cultures from hyperoxic injury.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8284092     DOI: 10.1203/00006450-199311000-00005

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  Epidermal growth factor reduces multiorgan failure induced by thioacetamide.

Authors:  M E Caballero; J Berlanga; D Ramirez; P Lopez-Saura; R Gozalez; D N Floyd; T Marchbank; R J Playford
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

2.  Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage.

Authors:  Jorge Berlanga; Pedro Prats; Diadelis Remirez; Ricardo Gonzalez; Pedro Lopez-Saura; Jorge Aguiar; Miriam Ojeda; Joseph J Boyle; Anthony J Fitzgerald; Raymond J Playford
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

3.  Structural and molecular regulation of lung maturation by intratracheal vascular endothelial growth factor administration in the normally grown and placentally restricted fetus.

Authors:  Erin V McGillick; Sandra Orgeig; Janna L Morrison
Journal:  J Physiol       Date:  2015-12-23       Impact factor: 5.182

4.  Mitochondrial oxidative stress is modulated by oleic acid via an epidermal growth factor receptor-dependent activation of glutathione peroxidase.

Authors:  Carine Duval; Nathalie Augé; Marie-Françoise Frisach; Louis Casteilla; Robert Salvayre; Anne Nègre-Salvayre
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

5.  Potential protective effects of rhEGF against ultraviolet A irradiation-induced damages on human fibroblasts.

Authors:  Ji Min Kim; Jung Eun Choo; Ki Nam Kim; Yang Seok Kim
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.